Transforming Healthcare. Transforming Lives. Company Overview

Transcription

1 Transforming Healthcare. Transforming Lives. Company Overview Kobi Graham, Australia One of the more than 9 million people transformed by a Medtronic product or therapy. Innovating for life.

2 The Medtronic Mission To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. ALLEVIATE PAIN. RESTORE HEALTH. EXTEND LIFE. This is our Mission at Medtronic. It s the reason we ve developed an unprecedented breadth and depth of innovative therapies over the past 60 years. And it s the reason millions of people s lives are improved by a Medtronic product or therapy each year. But we have more work to do. Our strategic vision is to address the three key universal healthcare needs: improve outcomes for better care, increase access to therapies so more people get treated, and improve the efficiency of healthcare delivery to reduce overall costs. It s why we re putting a greater emphasis on accelerating our globalization and demonstrating economic value. And it s why we continually drive harder, reach further, and push beyond the borders of conventional thinking. Because today, to transform more lives, we must also transform healthcare. 2 Medtronic Company Overview 3

3 AT A GLANCE The Global Leader in Medical Technology (Information reflects FY2013 data) OVERVIEW Revenue Sources Our businesses fall into three main groups. Cardiac and Vascular Group Cardiac Rhythm Disease Management $4,992 Coronary $1,773 Cardiac and Vascular Group (CVG) $8.7 Billion 9.6 MILLION PEOPLE S LIVES IMPROVED 140+ $64.4 MILLION TOTAL CHARITABLE CONTRIBUTIONS $33.7M $9.0M 46,000+ EMPLOYEES COUNTRIES 5,800+ SCIENTISTS AND ENGINEERS 350+ CLINICAL TRIALS Medtronic Philanthropy Foundation Giving* $21.7M Medical Device Donations** Cash Contributions*** $16.6 BILLION IN REVENUE 1,578 NEW PATENTS AWARDED U.S. 55% 26 RESEARCH CENTERS Geographic Revenue Mix South Asia Central and Eastern Europe Middle East and Africa 1% Latin America 1% 2% Greater China 2% 4% 11% 24% MORE THAN 28,000+ TOTAL PATENTS Asia Pacific Western Europe and Canada Restorative Therapies Group (RTG) Cardiac and Vascular Group Our Cardiac and Vascular Group (CVG) brings all Medtronic cardiac and vascular businesses together into one cross-functional, collaborative operating unit. CVG provides innovative and comprehensive solutions that extend beyond the industry s broadest portfolio of technologies to programs and services that drive economic value across the care continuum. PRODUCT CATEGORIES Ablation products Aortic stent graft systems Coronary angioplasty technologies CRDM device information management systems Electrophysiology catheters Implantable defibrillators Leads and delivery systems Open heart and coronary bypass grafting surgical products Pacemakers Peripheral angioplasty technologies Surgical heart valves Surgical Technologies $1,426 Restorative Therapies Group Neuromodulation $1,812 Restorative Therapies Group The Restorative Therapies Group (RTG) provides innovative, life-changing restorative therapies and services to meet the needs of millions of people worldwide who suffer from a wide range of chronic medical conditions. PRODUCT CATEGORIES Advanced energy surgical instruments Balloon kyphoplasty systems Bone graft and biologic products Deep brain stimulation devices and leads Devices for cranial trauma and tumors, critical care, and hydrocephalus Drug delivery devices and catheters Image-guided surgery and intra-operative imaging systems Products to treat conditions of the ear, nose, and throat Products to treat incontinence and gastroparesis Spinal cord stimulation devices and leads Spine motion preservation devices Group The Group (DG) at Medtronic is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software, as well as worldclass, 24/7 expert consumer and professional service and support. PRODUCT CATEGORIES External insulin pumps Subcutaneous continuous glucose monitoring systems Therapy management software Tissue ablation systems Thoracolumbar and cervical spine Transcatheter heart valves fixation systems * $28.3M paid in FY2013 and $5.4M deferred and paid in May for FY2013 commitments. Sales in emerging markets grew from 10 percent of total sales ** Estimated fair market value. in FY2012 to 11 percent in FY *** Medtronic cash giving includes support of medical conferences, charitable grants, Medtronic Company Overview 5 and research and public education programs. $6.4 Billion Spine $3,131 Structural Heart $1,133 FY2013 Revenue by Business (in millions) Endovascular $867 $1,526 Group (DG) $1.5 Billion

4 EVERY SECONDS another life is enhanced by a Medtronic 3product or therapy Our Therapies Chronic disease is the leading cause of mortality worldwide and a significant financial burden on society. Our products, therapies, and surgical technologies are used to treat many chronic conditions to help improve quality of life and advance healthcare. Cardiac Rhythm Ear, Nose, and Throat Atrial Fibrillation 2 Slow Heart Rates (Bradycardia) 18 Sinus Diseases 19 Thyroid Conditions 3 Fast Heart Rates (Tachycardia) 20 Otologic Disorders 4 Heart Failure 21 Sleep-Disordered Breathing Asymptomatic, Irregular Heart Rates 22 Pediatric Conditions Coronary 6 Coronary Artery Disease 23 Ménière s Disease Neurological Structural Heart 7 Heart Valve Disease 8 Congenital Heart Disease 24 Parkinson s Disease 25 Essential Tremor 26 Dystonia * 27 Hydrocephalus Endovascular 9 Peripheral Vascular Disease 10 Aortic Aneurysms 28 Obsessive-Compulsive Disorder * 29 Severe Spasticity associated with Multiple Sclerosis, Cerebral Palsy, Stroke, and Spinal Cord and Brain Injuries 30 Brain Tumors and Other Lesions Spinal and Orthopedic 31 Chronic Pain Cervical Degenerative Disc Disease 12 Scoliosis 32 Subdural Hematomas 33 Cranial Trauma 9 13 Degenerative Disc Disease 14 Spinal Fracture 15 Lumbar Spinal Stenosis 16 Tibial Fractures 17 Orthopedic Trauma * The Medtronic therapy for this disorder is available in the United States through a Humanitarian Device Exemption. The effectiveness of the therapy for this disorder has not been demonstrated. In addition to devices that treat these conditions, we offer Image-Guided Navigation Surgical Systems to help surgeons. Remote Monitoring available with select cardiac devices for clinicians to follow patients and their implanted cardiac devices remotely, eliminating the need for some in-office visits. Urological/Urogynecological and Gastroenterological 34 Overactive Bladder and Urinary Retention 35 Nausea and Vomiting associated with Gastroparesis * 36 Fecal Incontinence 37 We also offer advanced energy electrosurgical instruments indicated for use in orthopedic, spinal, thoracic, reconstructive plastic, surgical oncology, ear, nose, and throat (ENT), and general surgery procedures Updated July 2013 Medtronic Company Overview 7

5 Transforming Healthcare AROUND THE WORLD EXPAND ACCESS Mumbai, India IMPROVE OUTCOMES To help address the country s enormous noncommunicable disease burden, we train more than 4,000 physicians and surgeons annually to increase patient access, enhance diagnosing capabilities, and improve therapy quality. We serve physicians and patients in more than 140 countries around the world. Providing advanced medical technologies is only part of the picture. We re also spearheading programs to help increase access to available therapies, improve outcomes, and optimize cost and efficiency. EXPAND ACCESS IMPROVE OUTCOMES Barakaldo, Spain We partnered with Hospital de Cruces to create an advanced, integrated surgical area using our surgical navigation and imaging systems, which help surgeons see inside the body to perform more precise and less-invasive procedures. At our hands-on Patient Care Center, local patients get to see and touch the latest medical technologies through multimedia and 3-D models. Minneapolis, Minnesota In our world headquarters city, thousands of high school students have been trained to respond to a sudden cardiac arrest event as part of a Medtronic Philanthropysupported program aimed at improving survival rates. Beijing, China IMPROVE OUTCOMES OPTIMIZE EFFICIENCY Milan, Italy Mexico Through a unique partnership with distributors, we offer hospitals throughout the country bundled product ordering and delivery services to improve efficiency. 8 Among the many physicians who collaborate with us on product development is Dr. Michele Spinelli, who helped us improve our implantable neurostimulator to treat overactive bladder and urinary retention. EXPAND ACCESS Cape Town, South Africa Medtronic Philanthropy is supporting a Noncommunicable Disease Center of Excellence that is building diabetes and cardiovascular care models to better reach underserved populations in sub-saharan Africa. OPTIMIZE EFFICIENCY Singapore Medtronic employees at our Singapore manufacturing facility are producing muchneeded cardiac devices to help combat chronic disease in Asia. By manufacturing locally, we can get products to the region faster. Medtronic Company Overview 9

6 Transforming global healthcare by improving outcomes, expanding access, and enhancing value. 10 For more information about Medtronic, visit our website at

7 World Headquarters Medtronic, Inc. 710 Medtronic Parkway Minneapolis, MN USA Tel: Fax: UC a EN 2013 Medtronic, Inc. All Rights Reserved. Printed in USA.